Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Search Publications

Therapeutic Indication

Tech Segment

Reset

Mesenchymal Stem Cell Infiltration During Neoplastic Transformation of the Human Prostate

July 2017 Cancer, Cell Therapy

Procoagulant Activity of Human Mesenchymal Stem Cells

July 2017 Cell Therapy, Dermal and Wound

Cells as Advanced Therapeutics: State-of-the-art, Challenges, and Opportunities in Large Scale Biomanufacturing of High-quality Cells for Adoptive Immunotherapies

May 2017 Bioprocessing

Enhanced Non-viral Gene Delivery by Coordinated Endosomal Release and Inhibition of β-tubulin Deactylase

April 2017 Gene Editing, Immunomodulation

Hypoxic Expansion of Human Mesenchymal Stem Cells Enhances Three-Dimensional Maturation of Tissue-Engineered Intervertebral Discs

April 2017 Orthopedic, Tissue Engineering

Morphological Features of IFN-γ-stimulated Mesenchymal Stromal Cells Predict Overall Immunosuppressive Capacity

March 2017 Cell Therapy, Immunomodulation

In Vivo Chondrogenesis in 3D Bioprinted Human Cell-laden Hydrogel Constructs

February 2017 Bioprinting, Orthopedic, Tissue Engineering

Bioprocess Integration for Human Mesenchymal Stem Cells: From Up to Downstream Processing Scale-up to Cell Proteome Characterization

February 2017 Bioprocessing

Collagen Hydrogel Scaffold Promotes Mesenchymal Stem Cell and Endothelial Cell Coculture for Bone Tissue Engineering

February 2017 Bioprocessing, Orthopedic, Tissue Engineering

Deformability of Human Mesenchymal Stem Cells Is Dependent on Vimentin Intermediate Filaments

January 2017 Bioprocessing, Cell Therapy
Previous 1 2 3 4 … 57 58 59 60 61 62 63 64 Next

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email